Neutralizing IL-6 (178), IL-6 receptor (IL-6R) (179) or genetic IL-6 deletion (180) decreased disease severity in different experimental models of LN in MRL-Faslpr and NZB/WF1 mice. The gene discussed is IL6; the disease is lobular neoplasia.